Edwards Lifesciences Corporation Common Stock vs Kenvue Inc. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.19 (market cap $48.56B), while Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | KVUE | |
|---|---|---|
Market Cap | $48.56B | $34.06B |
Volume | 6,520,488 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $19.83 |
52-Week Low | $72.65 | $14.11 |
Enterprise Value | $45.01B | $41.56B |
Dividend Yield | — | 4.74% |
Trailing returns across standard periods
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →